POET Technologies Announces Pricing of US$150 Million Oversubscribed Registered Direct Offering of Common Shares

• The providing is being totally subscribed by two new elementary funding managers 
• Firm’s pro-forma money place anticipated to be in extra of US$300 million following closing

TORONTO, Oct. 26, 2025 (GLOBE NEWSWIRE) — POET Applied sciences Inc. (NASDAQ: POET) (the “Firm”), the designer and developer of the POET Optical Interposer™, Photonic Built-in Circuits (PICs) and lightweight sources for the information heart, tele-communication and synthetic intelligence markets, right this moment introduced that it has entered into securities buy agreements with institutional buyers for the acquisition and sale of 20,689,655 frequent shares in an oversubscribed registered direct providing. The providing is predicted to end in gross proceeds of roughly US$150 million, earlier than deducting providing bills. The closing of the providing is predicted to happen on or about October 28, 2025, topic to the satisfaction of customary closing situations.

Individuals within the providing embrace two new elementary funding managers.

The Firm intends to make use of the web proceeds from this funding for company improvement, together with focused acquisitions, scaling up of R&D, acceleration of the sunshine supply enterprise, increasing operations, and common working capital.

Titan Companions Group, a division of American Capital Companions, is appearing as the only real placement agent for the providing.

“POET’s Optical Interposer platform is a singularly elegant resolution to connectivity challenges at every degree of AI infrastructure, from chip-to-chip information communications to information switch inside the datacenter to the cellular networks that ship that information to customers”, mentioned Dr. Suresh Venkatesan, Govt Chairman & Chief Govt Officer of POET. “In every of those areas, we remodel info bottlenecks into information highways by marrying what is feasible in silicon to what’s highly effective in gentle. This extra funding by two main world funding funds provides immeasurably to POET’s potential to ship superior photonic options. With over US$300 million in money, we will speed up our pursuit of focused acquisitions, improve our capabilities and expertise, vertically combine our merchandise to enhance price and efficiency, and broaden operations to pursue income alternatives throughout the board, bringing long-term worth to shareholders.”

This providing is being made in the US solely pursuant to a shelf registration assertion on Type F-10 (File No. 333-280553) beforehand filed with the U.S. Securities and Trade Fee (the “SEC”) and declared efficient on September 10, 2024. The providing is made solely by way of a prospectus complement, which might be filed with the SEC and might be out there on the SEC’s web site situated at http://www.sec.gov. Digital copies of the prospectus complement could also be obtained, when out there, by contacting Titan Companions Group LLC, a division of American Capital Companions, LLC, 4 World Commerce Heart, forty ninth Ground, New York, NY 10007, by cellphone at (929) 833-1246 or by e-mail at prospectus@titanpartnersgrp.com.

This press launch shall not represent a suggestion to promote or the solicitation of a suggestion to purchase, nor shall there be any sale of those securities in any state or jurisdiction by which such supply, solicitation, or sale can be illegal previous to registration or qualification beneath the securities legal guidelines of any such state or jurisdiction.

About POET Applied sciences Inc.

POET is a design and improvement firm providing high-speed optical engines, gentle supply merchandise and customized optical modules to the unreal intelligence techniques market and to hyperscale information facilities. POET’s photonic integration options are primarily based on the POET Optical Interposer™, a novel, patented platform that enables the seamless integration of digital and photonic units right into a single chip utilizing superior wafer-level semiconductor manufacturing strategies. POET’s Optical Interposer-based merchandise are decrease price, devour much less energy than comparable merchandise, are smaller in dimension and are readily scalable to excessive manufacturing volumes. Along with offering high-speed (800G, 1.6T and above) optical engines and optical modules for AI clusters and hyperscale information facilities, POET has designed and produced novel gentle supply merchandise for chip-to-chip information communication inside and between AI servers, the following frontier for fixing bandwidth and latency issues in AI techniques. POET’s Optical Interposer platform additionally solves machine integration challenges throughout a broad vary of communication, computing and sensing functions. POET is headquartered in Toronto, Canada, with operations in Singapore, Penang, Malaysia and Shenzhen, China. Extra details about POET is offered on our web site at http://www.poet-technologies.com

About Titan Companions

Titan Companions Group, a division of American Capital Companions, is a boutique funding financial institution specializing in tailor-made options for publicly traded rising progress corporations. Titan Companions combines experience, belief, dedication, and a forward-thinking strategy to assist purchasers obtain their strategic capital wants.

Titan Companions Contact
data@titanpartnersgrp.com
4 World Commerce Heart, forty ninth Ground
New York, NY 10007
(929) 833-1246
http://www.titanpartnersgrp.com

Cautionary Notice Concerning Ahead-Wanting Data

This information launch comprises “forward-looking info” (inside the that means of relevant Canadian securities legal guidelines) and “forward-looking statements” (inside the that means of the U.S. Personal Securities Litigation Reform Act of 1995). Such statements or info are recognized with phrases similar to “anticipate”, “consider”, “anticipate”, “plan”, “intend”, “potential”, “estimate”, “suggest”, “venture”, “outlook”, “foresee” or related phrases suggesting future outcomes or statements concerning any potential end result. Such statements embrace, with out limitation, the Firm’s expectations with respect to the Firm’s merchandise, the scalability of the POET Optical Interposer and the success of the Firm’s merchandise, the Firm’s use of proceeds of this providing, the Firm’s money place and being well-capitalized upon the closing of the providing and the Firm having the ability to advance its enterprise aims. Such forward-looking info or statements are primarily based on numerous dangers, uncertainties and assumptions which can trigger precise outcomes or different expectations to vary materially from these anticipated and which can show to be incorrect. Assumptions have been made concerning, amongst different issues, administration’s expectations concerning the scale of the marketplace for its merchandise, the potential of its operations to supply merchandise on time and on the anticipated prices, the efficiency and availability of sure elements, and the success of its prospects in reaching market penetration for his or her merchandise. Precise outcomes may differ materially because of numerous components, together with, with out limitation, the attractiveness of the Firm’s product choices, efficiency of its know-how, the efficiency of key elements, and talent of its prospects to promote their merchandise into the market.

For additional info regarding these and different dangers and uncertainties, discuss with the Firm’s filings on SEDAR+ at http://www.sedarplus.ca and on the web site of the U.S. Securities and Trade Fee at http://www.sec.gov. Though the Firm believes that the expectations mirrored within the forward-looking info or statements are cheap, potential buyers within the Firm’s securities mustn’t place undue reliance on forward-looking statements as a result of the Firm can present no assurance that such expectations will show to be appropriate. Ahead-looking info and statements contained on this information launch are as of the date of this information launch and the Firm assumes no obligation to replace or revise this forward-looking info and statements besides as required by relevant securities legal guidelines.
120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 – Fax: 416-322-5075